| Not Yet Recruiting | MRI Technical Development and Applications in Kidney Disease NCT02421497 | University of Minnesota | — |
| Recruiting | Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD NCT07224763 | United Therapeutics | Phase 1 / Phase 2 |
| Not Yet Recruiting | Kidney Transplant Improvement Through New Exercise Training to Increase Capacity NCT07446296 | University of Pennsylvania | N/A |
| Not Yet Recruiting | Tubeless Spontaneous Ventilation Anesthesia in Kidney Transplantation NCT07377123 | Jianxing He | N/A |
| Not Yet Recruiting | Kidney Transplant Immunosuppressive Therapy Adherence Trial (KITE) NCT07364123 | University of Gaziantep | N/A |
| Not Yet Recruiting | A Qualitative Study on Gratitude and Recognition Toward Living Kidney Donors NCT07254546 | Assistance Publique - Hôpitaux de Paris | N/A |
| Not Yet Recruiting | Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Do NCT07379957 | University Hospital, Bordeaux | — |
| Recruiting | The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients NCT07275632 | First Affiliated Hospital of Chongqing Medical University | Phase 1 / Phase 2 |
| Not Yet Recruiting | Salivary Replication of BK Virus in Post-kidney Transplant NCT07256470 | Centre Hospitalier Universitaire, Amiens | N/A |
| Recruiting | Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD NCT06878560 | United Therapeutics | Phase 1 / Phase 2 |
| Not Yet Recruiting | CMV-associated Immunomodulation in Renal Transplant Patients NCT06976008 | Assistance Publique - Hôpitaux de Paris | N/A |
| Not Yet Recruiting | BmemHLA : Origins of the Heterogeneity of the Anti-HLA Memory B Cells in Kidney Transplantation NCT06956469 | University Hospital, Bordeaux | N/A |
| Recruiting | Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A P NCT06568549 | Mayo Clinic | Phase 4 |
| Recruiting | REgulatory T Cell Therapy to Achieve Immunosuppression REduction NCT06552169 | Singulera Therapeutics Inc. | Phase 2 |
| Recruiting | TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation NCT06829719 | Hospices Civils de Lyon | N/A |
| Active Not Recruiting | TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlati NCT07316829 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Recruiting | Prehabilitation for Kidney Transplant Candidates NCT06886256 | The Methodist Hospital Research Institute | N/A |
| Recruiting | Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation NCT06744647 | Alexion Pharmaceuticals, Inc. | Phase 2 |
| Not Yet Recruiting | Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients NCT06824454 | Stanford University | Phase 2 |
| Recruiting | Testing the Feasibility of a Self-Management Support Program for Patient With Chronic Diseases in Israel NCT07367750 | University of Haifa | N/A |
| Not Yet Recruiting | Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in L NCT06777719 | Nantes University Hospital | Phase 1 |
| Completed | Longitudinal Dynamics of AT1R Antibodies in Kidney Transplant Recipients NCT07374484 | Seoul National University Hospital | — |
| Not Yet Recruiting | Abnormalities of Preoperative Ascending Urethrocystography and Outcomes of Living Donor Kidney Transplantation NCT06735066 | Assiut University | — |
| Recruiting | Continuous Glucose Monitoring (CGM) After Kidney Transplantation NCT06675903 | Bo Feldt-Rasmussen | — |
| Recruiting | Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correla NCT06210555 | Patrick Schjelderup | — |
| Recruiting | BIOmarkers Before and After Kidney Transplantation NCT06810258 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTI NCT06341543 | University Hospital, Grenoble | N/A |
| Active Not Recruiting | Exercise and Prediabetes After Renal Transplantation NCT06576531 | University of La Laguna | N/A |
| Recruiting | Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch NCT06493526 | University Hospital, Antwerp | Phase 4 |
| Not Yet Recruiting | Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantati NCT06453135 | Tao Lin | Phase 1 / Phase 2 |
| Completed | Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision NCT05879302 | Hennepin Healthcare Research Institute | N/A |
| Unknown | Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccina NCT06307808 | University Hospital, Grenoble | — |
| Recruiting | Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantatio NCT06367205 | RenJi Hospital | N/A |
| Recruiting | Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialys NCT06591702 | Hacettepe University | — |
| Unknown | Illness Perception and Coping in Kidney Transplant Recipients: a Mixed Research Based on Common Sense Model NCT06195696 | Wu Jiangxue | — |
| Recruiting | Ex Vivo Normothermic Perfusion in Kidney Transplantation. NCT05175885 | Ebers Medical Technology, S.L. | N/A |
| Unknown | Renal Transplantation Nurse Training on Patient-Centered Care Competence and Counseling Skills NCT06015984 | Istanbul Gedik University | N/A |
| Recruiting | Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates NCT05917795 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Recruiting | Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hyper NCT05934383 | Erasmus Medical Center | N/A |
| Unknown | Development and Testing of the Kidney BEAM-KIDS Digital Platform for Children After Kidney Transplantation NCT05453656 | Queen Margaret University | N/A |
| Unknown | Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects NCT05948059 | Guangdong Hengrui Pharmaceutical Co., Ltd | Phase 1 |
| Completed | Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients NCT06512831 | West China Hospital | N/A |
| Not Yet Recruiting | Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation NCT05890430 | University Hospital, Strasbourg, France | — |
| Not Yet Recruiting | BAFF/APRIL in Kidney Transplant Rejection Risk Assessment NCT05779124 | First Affiliated Hospital, Sun Yat-Sen University | — |
| Unknown | Treg Cell Therapy in Liver and Kidney Transplantation - Preclinical Validation of Batches of Treg Cells Amplif NCT04661254 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Web-Based Multi-Resource Training on the Prevention of Urinary Tract Infections in Adult Kidney Transplant Rec NCT05821946 | Akdeniz University | N/A |
| Unknown | Normothermic Machine Perfusion (NMP) Versus Hypothermic Machine Perfusion (HMP) in Human Kidney Transplantatio NCT05743751 | Zhang Tianyu | N/A |
| Recruiting | Shingrix in Renal Transplant Recipients NCT04128189 | University of Colorado, Denver | Phase 3 |
| Terminated | A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) NCT04803006 | ITB-Med LLC | Phase 2 |
| Completed | Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT) NCT05013112 | West China Hospital | N/A |
| Active Not Recruiting | A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE) NCT04803058 | ITB-Med LLC | Phase 2 |
| Unknown | The Role of Endothelial Glycocalyx in Kidney Transplantation NCT05651906 | Charles University, Czech Republic | — |
| Recruiting | Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intens NCT06260579 | KU Leuven | N/A |
| Terminated | Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) NCT05511779 | SymBio Pharmaceuticals | Phase 2 |
| Completed | Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated? NCT05945511 | Seoul National University Hospital | — |
| Recruiting | Prevention of Incisional Hernia After Renal Transplantation NCT04794582 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | N/A |
| Completed | Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV G NCT04222023 | University Hospital, Strasbourg, France | Phase 4 |
| Completed | Trajectory of Immunosuppression-Caused Tremor In Kidney and Lung Transplant Recipients NCT06488651 | University Medical Center Groningen | — |
| Unknown | Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidne NCT05872815 | The Second Affiliated Hospital of Chongqing Medical University | — |
| Recruiting | Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation NCT05365672 | TolerogenixX GmbH | Phase 2 |
| Completed | Novel Desensitization Kidney Transplantation NCT05345717 | University of Chicago | Phase 1 / Phase 2 |
| Recruiting | Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocyte NCT04870437 | University Hospital, Angers | N/A |
| Completed | Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3 NCT04288271 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Completed | Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejecti NCT06436586 | Paris Translational Research Center for Organ Transplantation | — |
| Unknown | Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dial NCT05282875 | Central Hospital, Nancy, France | — |
| Completed | Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Compariso NCT05635136 | Centre Hospitalier William Morey - Chalon sur Saône | — |
| Completed | A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy NCT05152628 | Astellas Pharma China, Inc. | Phase 4 |
| Withdrawn | Selective CD28 Blockade in Renal Transplant Recipients NCT04903054 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Does an Abdominal Wall Nerve Block During Surgery Help Reduce Pain From Kidney Transplantation? NCT05280197 | The Cleveland Clinic | N/A |
| Withdrawn | AI for Allograft Diseases Diagnosis and Prognosis After Kidney Transplantation NCT05112770 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Incidence, Course and Outcome of ABMR in Kidney Transplantation NCT05140018 | University Medical Center Groningen | — |
| Completed | A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatri NCT05153915 | Astellas Pharma China, Inc. | Phase 4 |
| Completed | Feasibility of Magnetic-end Double-J Ureteral Stent Use in Children NCT04384939 | Assistance Publique - Hôpitaux de Paris | N/A |
| Terminated | Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR NCT04773392 | University of Southern California | Phase 4 |
| Active Not Recruiting | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Pati NCT05193565 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection NCT04934527 | University Hospital, Bordeaux | Phase 2 |
| Active Not Recruiting | Watermelon/UBIQuinone Study NCT04972552 | University of California, San Francisco | N/A |
| Completed | Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation. NCT04851145 | University Hospital, Bordeaux | N/A |
| Completed | Donor-derived Cell-free DNA in Kidney Transplant Recipients NCT06476717 | Institute for Clinical and Experimental Medicine | — |
| Completed | Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Ne NCT04779957 | University Hospital, Toulouse | Phase 2 |
| Active Not Recruiting | APOL1 Genetic Testing Program for Living Donors NCT04910867 | Northwestern University | N/A |
| Unknown | Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Vire NCT05026021 | Assistance Publique - Hôpitaux de Paris | — |
| Withdrawn | Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Resp NCT04936971 | Edoardo Melilli | Phase 4 |
| Unknown | RAKT OUTCOME ANALYSIS NCT06320821 | Seoul National University Hospital | — |
| Completed | EFFECT OF ADDING DAPAGLIFLOZIN TO ALLOGRAFT DYSFUNCTION OF RENAL TRANSPLANTED PATIENTS. NCT04743453 | University of Sao Paulo General Hospital | Phase 4 |
| Completed | Noninvasive Evaluation of Renal Allograft Fibrosis by MRI NCT04899167 | Mayo Clinic | N/A |
| Recruiting | Multiparametric MRI for Assessment of Changes of Renal Hemodynamics After Fistula Closure in Kidney Transplant NCT05015231 | University of Zurich | — |
| Unknown | Safety and Immunogenicity of 2-dose Inactivated COVID-19 Vaccine in Kidney Transplant Recipients NCT04969614 | West China Hospital | — |
| Completed | Determining the Effect of Individualized Education Program in Kidney Transplant Patients NCT06674239 | Fenerbahce University | N/A |
| Completed | Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study NCT04837092 | Nantes University Hospital | Phase 1 / Phase 2 |
| Completed | Molecular Markers of Acute Kidney Injury in Elderly Deceased Donors NCT06171438 | Institute for Clinical and Experimental Medicine | — |
| Terminated | A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation NCT06365437 | ITB-Med LLC | Phase 2 |
| Completed | A Dose Escalation Study in de Novo Renal Transplantation NCT04311632 | ITB-Med LLC | Phase 2 |
| Completed | Model-based Medication Dosing Assist for Tacrolimus in Kidney Transplantation NCT07030660 | KU Leuven | N/A |
| Completed | IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA) NCT04832841 | Institute for Clinical and Experimental Medicine | — |
| Withdrawn | Acthar for Treatment of Post-transplant FSGS NCT02399462 | University of North Carolina, Chapel Hill | Phase 4 |
| Unknown | Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients NCT04828460 | University Hospital, Strasbourg, France | — |
| Unknown | Motivational Interviewing for Adult Kidney Transplant Recipients NCT04956406 | Akdeniz University | N/A |
| Unknown | Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. NCT04700709 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Active Not Recruiting | Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation NCT04842591 | Medical University of Graz | — |
| Unknown | A Study of Retrograde Reperfusion of Renal Graft to Reduce Ischemic-reperfusion Injury NCT05179434 | West Kazakhstan Medical University | N/A |
| Completed | A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients NCT04587024 | Johns Hopkins University | N/A |
| Completed | ABO-Incompatible Kidney Transplants Between Robot-Assisted vs. Open Surgery NCT06287008 | Asan Medical Center | — |
| Completed | PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrol NCT04496401 | Nantes University Hospital | Phase 4 |
| Recruiting | Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplan NCT04791098 | University Hospital, Clermont-Ferrand | N/A |
| Recruiting | Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- Recipients NCT04562051 | West China Hospital | — |
| Unknown | Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients NCT04404127 | King Faisal Specialist Hospital & Research Center | Phase 4 |
| Unknown | Evaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation NCT04506060 | Centre Hospitalier Universitaire, Amiens | — |
| Unknown | Oxygenated Machine Preservation in Kidney Transplantation NCT04540640 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatib NCT04302805 | Institute for Clinical and Experimental Medicine | Phase 3 |
| Completed | Impact of P-gp, MRP2, ENT-1 and CNT3 on the Blood Concentration / Intra-PBMC Concentration of Tacrolimus NCT03910868 | Rennes University Hospital | — |
| Unknown | COVID-19 in Immunosuppressed Children NCT04511429 | D'Or Institute for Research and Education | — |
| Active Not Recruiting | Testing the Effect of KnowMAP (Knowledge Management for Renal Transplant Recipients). A Randomized Controlled NCT04296955 | Oslo University Hospital | N/A |
| Unknown | Magnesium Replacement and Hyperglycemia After Kidney Transplantation NCT04382157 | Oslo University Hospital | Phase 1 / Phase 2 |
| Unknown | Approach to Vascular Access After Renal Transplantation NCT04478968 | Wroclaw Medical University | — |
| Completed | Outcomes of Transrenal Artery Perfusion Versus Transrenal Vein Perfusion Using LifePort for Deceased Donor Kid NCT04569682 | West China Hospital | N/A |
| Completed | A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Pro NCT04046549 | Amgen | Phase 2 |
| Active Not Recruiting | Cell Therapy for Immunomodulation in Kidney Transplantation NCT03867617 | Thomas Wekerle | Phase 1 / Phase 2 |
| Unknown | Veloxis de Novo Kidney Transplant ECSWD NCT03828682 | Simon Tremblay, PharmD, PhD | Phase 4 |
| Active Not Recruiting | The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients NCT03809533 | Amit D Tevar, MD | Phase 2 |
| Terminated | CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients NCT03591380 | University of Wisconsin, Madison | Phase 2 |
| Completed | HLA-DQ in Acute Kidney Transplantation Rejection NCT03896919 | Assiut University | — |
| Completed | Living Donation and Kidney Transplantation Information NCT04285203 | State University of New York at Buffalo | N/A |
| Unknown | Study of Eplets Matching in Kidney Transplantation NCT03818698 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | Functional Non Specific Immunity Monitoring After Kidney Transplantation Using an Interferon Gamma Test NCT03572842 | Centre Hospitalier Universitaire de Nice | N/A |
| Active Not Recruiting | Envarsus XR® in Adolescent Renal Transplant Recipients NCT03266393 | University of California, Los Angeles | Phase 4 |
| Recruiting | EPI-STORM: Cytokine Storm in Organ Donors NCT03786991 | Université de Sherbrooke | — |
| Completed | A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients NCT03629080 | Hookipa Biotech GmbH | Phase 2 |
| Recruiting | Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates NCT03674307 | University of British Columbia | N/A |
| Completed | Genetic Factors on Outcomes of Kidney Transplant Patients With Tacrolimus-based Therapy NCT03764670 | National Taiwan University Hospital | — |
| Completed | Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclo NCT03663335 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN NCT03652402 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Preventive Fenestration With and Without Clipping in Kidney Transplantation NCT03682627 | University Hospital Heidelberg | N/A |
| Completed | Tolerance by Engaging Antigen During Cellular Homeostasis NCT03504241 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Unknown | Evaluation of the Respiratory Function in Renal Transplanted Children NCT03571542 | Nantes University Hospital | N/A |
| Completed | Video Education and Behaviour Contract to Optimize Adherence in Renal Transplants NCT03540121 | University of Saskatchewan | N/A |
| Unknown | Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration Plas NCT03436134 | University Hospital, Grenoble | N/A |
| Terminated | Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates NCT03507348 | University Hospital, Grenoble | N/A |
| Completed | Rejection Diagnosis in Kidney Transplants Patients NCT03582436 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Major Activation Of NCC in Graft Urinary Exosomes NCT03503461 | University Hospital, Bordeaux | — |
| Completed | Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant NCT03562845 | Biohope Scientific Solutions for Human Health, S.L. | — |
| Completed | Improving Adherence in Nonadherent Kidney Transplant Patients NCT03892317 | Imperial College London | N/A |
| Completed | Evaluation of 2 Techniques of Apheresis to Desensitize ABO Incompatible Kidney Transplant Candidates NCT03477656 | University Hospital, Toulouse | N/A |
| Completed | A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blo NCT03465969 | Astellas Pharma Europe Ltd. | Phase 4 |
| Completed | Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir NCT03631316 | Luis Eduardo Morales Buenrostro | N/A |
| Terminated | Contrast-Enhanced Ultrasound for Kidney Transplant NCT02911714 | University of Utah | Phase 1 |
| Completed | Cyclosporine a Pretreatment and Kidney Graft Function NCT02907554 | University Hospital, Clermont-Ferrand | Phase 4 |
| Unknown | Effect of Dexmedetomidine on Renal Function and Delayed Graft Function After Kidney Transplantation NCT03327389 | Yonsei University | N/A |
| Unknown | Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease NCT03090828 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation NCT03018041 | Joe Chan | Phase 3 |
| Completed | Preserve-Transplant Study NCT03102996 | University of Zurich | Phase 4 |
| Unknown | Efficacy Transverse Abdominal Plane (TAP) Block Renal Transplant Surgery NCT03181438 | Federal University of São Paulo | N/A |
| Completed | Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerul NCT02921789 | Astellas Pharma Global Development, Inc. | Phase 2 |
| Unknown | Intraabdominal Hypertension After Kidney Transplantation NCT03478176 | CHU de Reims | — |
| Unknown | Urinary Tract Infections in Kidney Transplant Recipients NCT03211026 | Poitiers University Hospital | — |
| Completed | OPTImization of the Dose of tacroliMUS by Bayesian Prediction NCT03465410 | NURIA LLOBERAS BLANCH | Phase 4 |
| Unknown | Efficiency of a Whole Body Vibration Training Program in Adult Renal Transplanted Patients NCT03120377 | Universidade Federal de Pernambuco | N/A |
| Completed | Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Stu NCT02970630 | Chiesi Farmaceutici S.p.A. | Phase 2 |
| Completed | Information and Communication Technology (ICT) Based Centralized Clinical Trial Monitoring System for Drug Adh NCT03136588 | Kyungpook National University Hospital | N/A |
| Completed | The Feasibility and Safety of Normothermic ex Vivo Kidney Perfusion NCT03136848 | University Health Network, Toronto | N/A |
| Completed | Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease NCT02997046 | Sokratis Stoumpos | — |
| Completed | To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Format NCT02723591 | Astellas Pharma Global Development, Inc. | Phase 4 |
| Unknown | Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Tran NCT02908139 | Medical University of Warsaw | — |
| Completed | Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IV NCT02878616 | Novartis Pharmaceuticals | Phase 1 |
| Unknown | Individual and Dyadic Functioning, Adherence, and Quality of Life After Kidney Transplantation NCT02681770 | Hannover Medical School | — |
| Unknown | Iguratimod in Kidney Transplant Recipients NCT02839941 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Completed | Enhancing Kidney Donation Through Live Organ Video Educated Donors (LOVED) Study Phase NCT03599102 | Medical University of South Carolina | N/A |
| Unknown | Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in P NCT02729116 | Khon Kaen University | Phase 2 / Phase 3 |
| Unknown | Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation NCT03134625 | Seoul National University Hospital | — |
| Completed | Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus NCT02576366 | Universitaire Ziekenhuizen KU Leuven | Phase 4 |
| Completed | Smart Phone Medication Adherence Saves Kidneys--SMASK NCT02827695 | Medical University of South Carolina | N/A |
| Unknown | Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients NCT02808065 | Seoul National University Hospital | — |
| Completed | IVIg to Treat BK Viremia in Kidney Transplant Recipients NCT02659891 | Massachusetts General Hospital | Phase 1 |
| Completed | Measurements of Kidney Perfusion After Transplantation by Intraoperative Fluorescence Angiography NCT02775838 | University Hospital Erlangen | Phase 2 |
| Unknown | Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney T NCT03425071 | University of Sao Paulo General Hospital | — |
| Unknown | Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients NCT02644915 | Xijing Hospital | N/A |
| Completed | Effect of Privigen Against Graft Loss NCT02374736 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | The Use of the Social Networking to Promote Educational and Consultative Actions Among Kidney Transplanted Ado NCT03214965 | Instituto de Cardiologia do Rio Grande do Sul | N/A |
| Completed | A Predictive Model for Postoperative Delirium in Kidney Transplant Patients NCT07078578 | Hua Zheng | — |
| Unknown | The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentrat NCT02707822 | National Taiwan University Hospital | — |
| Unknown | An US Mathematical Model in Predicting Renal Transplant Rejection NCT03045731 | Shanghai Zhongshan Hospital | — |
| Completed | Regimen Optimization Study NCT02137239 | Bristol-Myers Squibb | Phase 2 |
| Unknown | Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant. NCT02563366 | First Affiliated Hospital, Sun Yat-Sen University | Phase 1 / Phase 2 |
| Completed | Pre-formed Alloreactivity in Renal Transplant Recipients NCT02633826 | Martina Sester | — |
| Unknown | Effect of BM-MSCs on Chronic AMR After Kidney Transplantation NCT02563340 | First Affiliated Hospital, Sun Yat-Sen University | Phase 1 / Phase 2 |
| Unknown | Effect of BM-MSCs in DCD Kidney Transplantation NCT02561767 | First Affiliated Hospital, Sun Yat-Sen University | Phase 1 / Phase 2 |
| Terminated | Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation NCT02417870 | Anil K. Chandraker, MD | Phase 1 / Phase 2 |
| Completed | Bela 8 Week Dosing NCT02560558 | Emory University | Phase 4 |
| Completed | TOlerance MOlecular and Genome-wide Studies With Renal Allograft Recipient Material NCT05124444 | Université Libre de Bruxelles | N/A |
| Unknown | Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function NCT02568696 | Helsinki University Central Hospital | — |
| Completed | A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients NCT02444143 | University of Illinois at Chicago | Phase 4 |
| Unknown | Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Rec NCT03173820 | Khon Kaen University | N/A |
| Unknown | Do Technology Apps Improve Compliance in Adolescent Renal Transplant Recipients? NCT02610946 | Stanford University | N/A |
| Completed | Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients NCT02555787 | Astellas Pharma Europe Ltd. | — |
| Unknown | BIOMARGIN European, Ambispective Cohort of Adult and Paediatric Renal Transplant Patients NCT02832661 | University Hospital, Limoges | — |
| Completed | Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney Transplantat NCT03623217 | Astellas Pharma Korea, Inc. | — |
| Completed | CCFZ533X2201 - PoC Study in de Novo Renal Transplantation NCT02217410 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Unknown | Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation NCT02351427 | Asan Medical Center | Phase 3 |
| Completed | A Randomized Control Trial of Antibiotic Treatment Duration For Asymptomatic Bacteriuria After Kidney Transpla NCT02575495 | Mahidol University | Phase 2 |
| Terminated | Whole-body Vibration Physiotherapy in Kidney Transplantation NCT02345577 | Insel Gruppe AG, University Hospital Bern | N/A |
| Completed | Therapeutic Drug Monitoring (TDM) of Cyclosporine in Kidney Transplant Patients by Dried Blood Spot Assay. Int NCT02830191 | University Hospital, Caen | — |
| Completed | Evaluation of CAF22 After Renal Transplantation NCT02346968 | Insel Gruppe AG, University Hospital Bern | — |
| Completed | iChoose Decision Kidney Aid for End-Stage Renal Disease Patients NCT02235571 | Emory University | N/A |
| Completed | Pre-emptive Kidney Transplantation Quality of Life NCT02154815 | Nantes University Hospital | — |
| Completed | Bone Mass and Strength After Kidney Transplantation NCT02224144 | Columbia University | Phase 2 |
| Unknown | Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibod NCT02208791 | University of Sao Paulo General Hospital | Phase 4 |
| Completed | Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation NCT02161237 | Astellas Pharma Inc | Phase 4 |
| Completed | The Effects of Pre-operative Anxiety on Anesthetic Recovery and Post-operative Pain in Donor Nephrectomy NCT03131258 | Ege University | N/A |
| Terminated | ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF NCT02056938 | Nantes University Hospital | Phase 4 |
| Completed | The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in th NCT01871753 | Erasme University Hospital | Phase 4 |
| Terminated | Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT) NCT02081729 | Asan Medical Center | — |
| Completed | Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Spe NCT02550639 | ORIOL BESTARD | Phase 4 |
| Withdrawn | Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring NCT02058875 | University of Saskatchewan | Phase 4 |
| Terminated | BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance NCT02029638 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Impact of Arterial Stiffness and Central Aortic Blood Pressure on Kidney Transplant Outcomes NCT02000869 | Louisiana State University Health Sciences Center Shreveport | — |
| Unknown | Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation NCT02782416 | National Taiwan University Hospital | N/A |
| Withdrawn | Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Pa NCT02062892 | University of Colorado, Denver | Phase 4 |
| Completed | Efficacy of Belatacept in Reducing DSA NCT02078193 | East Carolina University | Phase 4 |
| Unknown | CEUS in Kidney and Pancreas Transplantation NCT02104024 | University of Manchester | — |
| Completed | Bile Acids and Incretins in Pancreas Kidney Transplant Patients NCT02234349 | Hospices Civils de Lyon | N/A |
| Unknown | ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Pati NCT01905514 | Seoul National University Hospital | N/A |
| Completed | Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1 NCT02147210 | University Hospital, Toulouse | — |
| Unknown | Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression NCT01875224 | University of Arizona | Phase 4 |
| Terminated | Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation NCT01919346 | Heeger, Peter, M.D. | Phase 2 |
| Completed | Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients NCT02083042 | Lophius Biosciences GmbH | — |
| Completed | Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney NCT01895049 | Helio Tedesco Silva Junior | Phase 4 |
| Terminated | Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen NCT01856257 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients NCT01771705 | University of California, San Francisco | N/A |
| Completed | Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibr NCT01860183 | Clinical Hospital Merkur | Phase 4 |
| Terminated | Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients NCT01817699 | CANDLE-KIT Trial Study Group | Phase 4 |
| Completed | A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based NCT01820572 | Bristol-Myers Squibb | Phase 3 |
| Completed | A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients NCT01780844 | Astellas Pharma Global Development, Inc. | Phase 2 |
| Unknown | EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety NCT01834768 | CHU de Reims | Phase 2 |
| Completed | Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus NCT02644395 | Erasmus Medical Center | Phase 3 |
| Completed | Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kid NCT01842269 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine NCT01781871 | Helsinki University Central Hospital | Phase 4 |
| Completed | 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients NCT01843348 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney Trans NCT02459470 | Samsung Medical Center | N/A |
| Withdrawn | A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients NCT01649388 | Talaris Therapeutics Inc. | Phase 2 |
| Completed | Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk NCT01702207 | University of Saskatchewan | Phase 4 |
| Unknown | The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients NCT01699360 | Central South University | Phase 4 |
| Completed | Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors NCT01653041 | Hospital do Rim e Hipertensão | Phase 4 |
| Completed | Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation NCT01622881 | Severance Hospital | N/A |
| Completed | Effectiveness of an APN-led Self-management Program in Patients in the First Year After Renal Transplantation NCT02282124 | University of Zurich | N/A |
| Completed | A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medicat NCT01614665 | Astellas Pharma Europe Ltd. | Phase 2 |
| Unknown | The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea NCT02459977 | Asan Medical Center | N/A |
| Completed | Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China NCT01796639 | Novartis | — |
| Completed | Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study NCT01471223 | Bristol-Myers Squibb | — |
| Completed | A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation NCT02432053 | Astellas Pharma Inc | Phase 4 |
| Completed | Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant NCT01386359 | Bristol-Myers Squibb | — |
| Completed | Intervention to Improve Adherence in Teen Kidney Transplant NCT01356277 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Completed | Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation NCT01897961 | Centre Hospitalier Universitaire de Nice | N/A |
| Terminated | Protocol DIVAT-Uro NCT01280708 | Nantes University Hospital | — |
| Completed | Left Ventricular Diastolic Dysfunction in Kidney Recipients NCT02322567 | Severance Hospital | — |
| Terminated | A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients NCT01442337 | Astellas Pharma Inc | Phase 2 / Phase 3 |
| Completed | Everolimus in de Novo Kidney Transplant Recipients NCT01410448 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Kidney Allograft Recipients in England - an Observational Cohort Study NCT01798524 | University Hospital Birmingham NHS Foundation Trust | — |
| Completed | Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients NCT01656343 | Bristol-Myers Squibb | — |
| Withdrawn | Alefacept in Kidney Transplant Recipients NCT01433770 | University Hospitals Cleveland Medical Center | N/A |
| Unknown | Study of Subclinical Viral Infection NCT01615341 | Seattle Children's Hospital | — |
| Completed | Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation NCT01655563 | The Hospital for Sick Children | Phase 2 |
| Terminated | Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation NCT01436305 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Contai NCT01672957 | Hoffmann-La Roche | — |
| Completed | Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients NCT01375127 | Pfizer | — |
| Completed | Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection NCT01134510 | Stanley Jordan, MD | Phase 1 / Phase 2 |
| Completed | The Effect of Remote Postconditioning on Graft Function in Patients Undergoing Living-related Kidney Transplan NCT01363687 | Samsung Medical Center | N/A |
| Completed | Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients NCT01476488 | Seoul National University Hospital | Phase 2 / Phase 3 |
| Completed | Study Investigating Rapamune For Post-Marketing Surveillance NCT00484094 | Pfizer | — |
| Terminated | A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipient NCT01371344 | Astellas Pharma Europe Ltd. | Phase 4 |
| Completed | A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Org NCT01371331 | Astellas Pharma Europe Ltd. | Phase 4 |
| Completed | Prediction of Chronic Allograft Nephropathy NCT01380847 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graf NCT01395719 | University of Aarhus | N/A |
| Completed | Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Pr NCT01294020 | Astellas Pharma Europe Ltd. | Phase 2 |
| Completed | Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Ki NCT01560572 | University Medical Center Groningen | Phase 4 |
| Completed | A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modif NCT01742676 | Astellas Pharma Korea, Inc. | Phase 4 |
| Completed | A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication In NCT01363752 | Astellas Pharma Inc | Phase 4 |
| Completed | Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients NCT01289717 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Withou NCT01304836 | Astellas Pharma Inc | Phase 4 |
| Unknown | Thymoglobulin Induction in Kidney Transplant Recipients NCT01239563 | University of Oxford | Phase 3 |
| Withdrawn | Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation NCT01035593 | Pharming Technologies B.V. | Phase 2 |
| Completed | Anti-BK Virus Immune Response and Kidney Transplantation NCT01109186 | Nantes University Hospital | — |
| Completed | A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Tran NCT01279538 | Astellas Pharma Inc | Phase 1 |
| Terminated | Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recip NCT02730715 | University of Pennsylvania | — |
| Completed | Conventional Laparoscopic Versus Laparoendoscopic Single Site Donor Nephrectomy in Living Donor Kidney Transpl NCT01236326 | Weill Medical College of Cornell University | N/A |
| Completed | Study of Sodium Bicarbonate in Kidney Transplant Recipients NCT01225796 | University of Utah | EARLY_Phase 1 |
| Terminated | Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients NCT01213394 | Ramesh Prasad | Phase 3 |
| Completed | Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant NCT01271465 | Weill Medical College of Cornell University | — |
| Completed | A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Tran NCT01839929 | Astellas Pharma Korea, Inc. | Phase 4 |
| Completed | Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy NCT01120028 | University of Oxford | Phase 2 / Phase 3 |
| Completed | Associating Renal Transplantation With the ITN Signature of Tolerance NCT01516177 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes NCT01143532 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients NCT01114529 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) S NCT01300416 | Novartis Pharmaceuticals | — |
| Withdrawn | Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantatio NCT01033500 | University of Wisconsin, Madison | N/A |
| Completed | Medical Economic Evaluation and of Quality of Life of the Kidney Living Donors. NCT02830568 | Central Hospital, Nancy, France | — |
| Withdrawn | Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation NCT01149993 | Georgetown University | Phase 4 |
| Terminated | A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Tra NCT02963103 | Astellas Pharma Korea, Inc. | Phase 4 |
| Completed | Mucosal Response in Immunocompromised Host NCT01109914 | Leiden University Medical Center | Phase 4 |
| Completed | Treatment of the optImuM Dose of calcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients NCT01159080 | Asan Medical Center | Phase 4 |
| Completed | Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy NCT01197573 | The Cleveland Clinic | N/A |